title: P53 and breast cancer.
abstract: p53 mutation is the most common genetic abnormality found so far in human cancer, and in breast cancer p53 mutation/alteration is seen in up to 50% of primary carcinomas. Together with the increasing knowledge of the characteristics and understanding of the role of p53 over the last two decades, attention in recent years has been focused on how this knowledge can be used in clinical settings for patient care and management in terms of analyzing p53 as a potential marker for studying the relationship between p53 expression and tumour development, progression and outcome; and designing alternative treatment strategies specifically aimed at restoring normal p53 function.
authors.affiliation: Department of Surgery and Molecular Oncology, Ninewells Hospital and Medical School, Dundee DD1 9SY, UK. dziyaie@hotmail.com
authors.forename: D
authors.initials: D
authors.lastname: Ziyaie
authors.forename: T R
authors.initials: TR
authors.lastname: Hupp
authors.forename: A M
authors.initials: AM
authors.lastname: Thompson